Contribution: Industrial Research Assistance Program – Contributions to Firms
Reverb Therapeutics Inc.
$530,500.00
Development of the Amplifier antibody platform, its proof of concept and a therapeutic candidate.
FY 2023-24 · 2023-10-15
Summary
This project will develop and characterize the function of Amplifier antibodies, a novel class of multispecific antibodies that engage cytokines and redirect them to a desired tissue or target cell for enhanced exposure and targeted activity.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
748263746
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-10-15 | 2023-24 | $251,000.00 |
| 1 | 2023-10-15 | 2023-24 | $530,500.00 |
| 2 | 2023-10-15 | 2023-24 | $530,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 61 jours.
Agreement End Date
2024-11-30
Agreement Number
1013408
Agreement Start Date
2023-10-15
Agreement Title
Development of the Amplifier antibody platform, its proof of concept and a therapeutic candidate.
Agreement Title (French)
Développement de la plateforme d’anticorps Amplifier, de sa preuve de concept et d’un candidat au traitement.
Agreement Type
Contribution
Agreement Value
$530,500.00
Amendment Date
2024-09-24
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will develop and characterize the function of Amplifier antibodies, a novel class of multispecific antibodies that engage cytokines and redirect them to a desired tissue or target cell for enhanced exposure and targeted activity.
Description (French)
Ce projet développera et caractérisera la fonction des anticorps Amplifier, une nouvelle classe d’anticorps multispécifiques qui engagent les cytokines et les redirigent vers un tissu désiré ou une cellule cible pour une meilleure exposition et une activité ciblée.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
748263746
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Reverb Therapeutics Inc.
Recipient Postal Code
V7Y 1B3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2023-2024-Q3-1013408
